← Leaderboards
Daniel Abate-Daga
H. Lee Moffitt Cancer Ctr & Res Inst
$2,954,893
Attributed
$2,954,893
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $659.8K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,954,893 · 3
By mechanism
R01$2,371,259 · 1
R21$421,440 · 1
P30$162,194 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Performance”
- Leonard Freedman · Leidos Biomedical Research, Inc.$272,749,741
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Kimberly Smith · Ppd Development Lp$115,671,664
- Lynn Briscoe · Leidos Biomedical Research, Inc.$105,069,915
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Leonard Freedmand · Leidos Biomedical Research, Inc.$63,100,245
Research focus
PerformanceImmuneChimeric Antigen Receptor T CellsChimeric Antigen ReceptorNeoplastic CellCellsSolidImmunotherapyPreventMouse ModelOverexpressionSignal Pathwayî³î´ T CellsPre-ClinicalGeneticIn VivoBindingClinical TrialsDesignGenerationsCd8b1 GeneCytotoxicMolecularMalignant Neoplasms
Grant awards (9)
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.$413,715
R01 · FY2024 · CA · contact PI
KIR2DL2 Immune Checkpoint as Modulator of T-Cell Effector Function$224,506
R21 · FY2024 · CA · contact PI
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.$462,850
R01 · FY2023 · CA · contact PI
KIR2DL2 Immune Checkpoint as Modulator of T-Cell Effector Function$196,934
R21 · FY2023 · CA · contact PI
Cell Therapies Core$1
P30 · FY2023 · CA · contact PI
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.$489,115
R01 · FY2022 · CA · contact PI
Cell Therapies Core$162,193
P30 · FY2022 · CA · contact PI
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.$501,190
R01 · FY2021 · CA · contact PI
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.$504,389
R01 · FY2020 · CA · contact PI